A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension
Clinical trial NCT07660796 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07660796
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-06
- Primary completion
- 2027-10-30
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.